First randomized controlled trial of FMT for obesity shows potential progress

Using capsules filled with fecal matter from a lean donor, researchers successfully changed some of the composition of the gut microbiota of patients with obesity, a possible step toward a new treatment for weight loss. In the first randomized controlled trial of fecal microbiota transplantation (FMT) in metabolically healthy people with obesity, researchers presenting at Digestive Disease Week® (DDW) 2019 said they were encouraged they could induce changes among the trillions of microorganisms and their genetic material within the intestinal tract.
Source: EurekaAlert,